American Society of Breast Surgeons: Innovative Lymphedema Surveillance Program and Early Intervention Significantly Help Prevent Progression
DALLAS--(BUSINESS WIRE)--May 2, 2019--Surveillance of women at risk for breast cancer-related lymphedema using bioimpedance spectroscopy (BIS) was more effective in preventing lymphedema progression than traditional arm circumference measurement, when each is combined with immediate compression therapy. These were the results of an interim analysis of 508 patients in a large, multi-site, international, randomized controlled trial comparing the detection of early lymphatic impairment using technology that directly measures extracellular fluid with conventional tape measure (TM) assessment. They were presented this week at the annual meeting of the American Society of Breast Surgeons.
“Breast cancer-related lymphedema is a chronic, debilitating swelling of the arm that may result from surgery, radiation, or chemotherapy affecting the lymph nodes. Lymphedema significantly lowers quality-of-life and consistently ranks as the number one fear of breast cancer survivors,” says lead study author Sheila Ridner, PhD, RN, FAAN, Vanderbilt University School of Nursing.
She adds that this is the first trial of this type to demonstrate the efficacy of BIS over TM assessment to prevent progression of lymphedema through early lymphatic impairment detection, followed by immediate intervention with compression therapy using specially fitted sleeves and gauntlets.
“This study suggests that BIS is a highly effective tool for pinpointing patients at risk,” Ridner says, noting that fewer women went on to develop clinical lymphedema when referred for therapy using BIS than TM. …Cont.
LINK TO FULL PRESS KIT FROM AMERICAN SOCIETY OF BREAST SURGEONS ANNUAL MEETING PRESS CONFERENCE, WITH FULL RELEASE AND ADDITIONAL PRESS RELEASES ON:
- Reduced Opioid Prescription Program Supports Effective Post-Operative Pain Management
- Well-Selected Elevated Risk Nipple-Sparing Surgery Patients Experience No Increase in Surgical and Reconstruction Risks
- Surgery May be Unnecessary for Appropriately Selected HER2+ Patients in the Future
- Same-Day Home Surgical Recovery Programs Benefit Recovery and Enhance Patient Experience, with No Increased Risks
View source version on businesswire.com:https://www.businesswire.com/news/home/20190502005640/en/
CONTACT: Molly McDougall
KEYWORD: UNITED STATES NORTH AMERICA TEXAS
INDUSTRY KEYWORD: WOMEN SURGERY HEALTH CLINICAL TRIALS MEDICAL DEVICES ONCOLOGY RADIOLOGY RESEARCH OTHER SCIENCE CONSUMER SCIENCE
SOURCE: American Society of Breast Surgeons
Copyright Business Wire 2019.
PUB: 05/02/2019 12:30 PM/DISC: 05/02/2019 12:30 PM